Astria Therapeutics : - 2024 Proxy Statement

ASTRIA THERAPEUTICS, INC.


75 State Street, Suite 1400


Boston, MA 02109


NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
...

Related Keywords

Boston ,Massachusetts ,United States ,Joanne Beck ,Hugh Cole ,Jillc Milne ,Gregg Lapointe ,Wilmer Cutler Pickering Hale ,Michael Kishbauch ,Sunil Agarwal ,Fred Callori ,Ernst Young ,Roche Holdings Inc ,Biology At Cornell University ,Myokardia Inc ,Exchange Commission ,Equiniti Trust Company ,Corporation Law Of The State Delaware ,Alliance Advisors ,Board Of Directors Astria Therapeutics Inc ,Astria Therapeutics Inc ,Arvinas Inc ,Meeting Of Stockholders Astria Therapeutics Inc ,Bristol Myers Squibb ,Global Head Of Clinical Development ,Sana Biotechnology Inc ,Genentech Inc ,Calithera Biosciences Inc ,Ultragenyx Pharmaceutical Inc ,Juno Therapeutics Inc ,Astria Therapeutics ,Annual Meeting ,Incentive Plan ,Internet Availability ,Proxy Materials ,Annual Report ,Chief Executive Officer ,Notice Regarding ,Corporate Secretary ,Directors Recommendation ,Second Amended ,Can Vote ,Seriesx Preferred Stock ,Shares Held ,Measures Considered ,Beach Proposal ,Counting Votes ,Changing Your Vote ,Proxy Solicitation ,Current Report ,General Corporation Law ,Classi Directors ,Kenneth Bate ,Jonathan Violin ,Each Class ,Three Year Term Expiring ,Executive Vice President ,Chief Development Officer ,Sana Biotechnology ,Juno Therapeutics ,Sofinnova Ventures ,Chief Medical Officer ,Senior Vice President ,Roche Holdings ,Global Head ,Clinical Development ,Infectious Diseases ,Vice President ,Genentech Drug ,Calithera Biosciences ,Cornell University ,Markets ,